These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 15664056)

  • 21. Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants.
    Quan Y; Liang C; Brenner BG; Wainberg MA
    J Infect Dis; 2009 Nov; 200(9):1479-83. PubMed ID: 19758098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.
    Kinomoto M; Yokoyama M; Sato H; Kojima A; Kurata T; Ikuta K; Sata T; Tokunaga K
    J Virol; 2005 May; 79(10):5996-6004. PubMed ID: 15857986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
    Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
    AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of drug-resistant HIV-1 strains.
    Kiessling AA; Eyre SJ; Desmarais BD
    Methods Mol Biol; 2005; 304():287-313. PubMed ID: 16061984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry.
    Brockman MA; Tanzi GO; Walker BD; Allen TM
    J Virol Methods; 2006 Feb; 131(2):134-42. PubMed ID: 16182382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region.
    Villena C; Prado JG; Puertas MC; Martínez MA; Clotet B; Ruiz L; Parkin NT; Menéndez-Arias L; Martinez-Picado J
    J Virol; 2007 May; 81(9):4713-21. PubMed ID: 17314158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal.
    Zhang J; Liu Y; Henao J; Rugeles MT; Li J; Chen T; He JJ
    Gene; 2005 Dec; 363():67-76. PubMed ID: 16236470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line.
    Mansky LM
    AIDS Res Hum Retroviruses; 1996 Mar; 12(4):307-14. PubMed ID: 8906991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous mutant frequency and mutation spectrum for gene A of phiX174 grown in E. coli.
    Raney JL; Delongchamp RR; Valentine CR
    Environ Mol Mutagen; 2004; 44(2):119-27. PubMed ID: 15278916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High fidelity of homologous retroviral recombination in cell culture.
    Bircher LA; Rigano JC; Ponferrada VG; Wooley DP
    Arch Virol; 2002 Sep; 147(9):1665-83. PubMed ID: 12209308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector.
    Rawson JM; Clouser CL; Mansky LM
    Methods Mol Biol; 2016; 1354():71-88. PubMed ID: 26714706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of a linear algebra to the analysis of mutation rates.
    Jones ME; Thomas SM; Clarke K
    J Theor Biol; 1999 Jul; 199(1):11-23. PubMed ID: 10419757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1.
    Cassidy T; Stephenson KE; Barouch DH; Perelson AS
    PLoS Comput Biol; 2024 Mar; 20(3):e1011518. PubMed ID: 38551976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term experimental evolution of HIV-1 reveals effects of environment and mutational history.
    Bons E; Leemann C; Metzner KJ; Regoes RR
    PLoS Biol; 2020 Dec; 18(12):e3001010. PubMed ID: 33370289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A High-Throughput HIV-1 Drug Screening Platform, Based on Lentiviral Vectors and Compatible with Biosafety Level-1.
    Ellinger B; Pohlmann D; Woens J; Jäkel FM; Reinshagen J; Stocking C; Prassolov VS; Fehse B; Riecken K
    Viruses; 2020 May; 12(5):. PubMed ID: 32466195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Determination of HIV-1 RT Mutation Rate, Its Possible Allosteric Effects, and Its Implications on Drug Resistance.
    Yeo JY; Goh GR; Su CT; Gan SK
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32182845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the mutational fitness effects distribution during early HIV infection.
    Bons E; Bertels F; Regoes RR
    Virus Evol; 2018 Jul; 4(2):vey029. PubMed ID: 30310682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of viral mutation.
    Sanjuán R; Domingo-Calap P
    Cell Mol Life Sci; 2016 Dec; 73(23):4433-4448. PubMed ID: 27392606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.